サイトメガロウイルス病治療の世界市場2019

GlobalInfoResearchが発行した調査報告書（GIR9101582）

◆英語タイトル：Global Cytomegalovirus Disease Treatments Market 2019 by Company, Regions, Type and Application, Forecast to 2024
◆商品コード：GIR9101582
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2019年9月（※2024年版があります。お問い合わせください）
◆ページ数：117
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥515,040	見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）	USD5,220 ⇒換算￥772,560	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,030,080	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは、サイトメガロウイルス病治療の世界市場について調べ、まとめました。種類別セグメントは、ガンシクロビル、バルガンシクロビル、フォスカルネット、シドフォビル、その他等、用途別セグメントは、幹細胞移植、臓器移植、先天性CMV感染、その他等に区分しました。サイトメガロウイルス病治療の世界市場概観、企業動向、企業別サイトメガロウイルス病治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・サイトメガロウイルス病治療の市場概観
・サイトメガロウイルス病治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・サイトメガロウイルス病治療の企業別販売動向、市場シェア、市場集中度、競争動向
・サイトメガロウイルス病治療の世界市場規模
・サイトメガロウイルス病治療の北米市場分析（アメリカ、カナダ、メキシコ等）
・サイトメガロウイルス病治療のアメリカ市場規模推移
・サイトメガロウイルス病治療のカナダ市場規模推移
・サイトメガロウイルス病治療のメキシコ市場規模推移
・サイトメガロウイルス病治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・サイトメガロウイルス病治療のドイツ市場規模推移
・サイトメガロウイルス病治療のイギリス市場規模推移
・サイトメガロウイルス病治療のロシア市場規模推移
・サイトメガロウイルス病治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・サイトメガロウイルス病治療の日本市場規模推移
・サイトメガロウイルス病治療の中国市場規模推移
・サイトメガロウイルス病治療の韓国市場規模推移
・サイトメガロウイルス病治療のインド市場規模推移
・サイトメガロウイルス病治療の東南アジア市場規模推移
・サイトメガロウイルス病治療の南米市場分析（ブラジル、アルゼンチン等）
・サイトメガロウイルス病治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・サイトメガロウイルス病治療の種類別分析/販売量、売上、市場シェア（ガンシクロビル、バルガンシクロビル、フォスカルネット、シドフォビル、その他）
・サイトメガロウイルス病治療の用途別分析/市場規模（幹細胞移植、臓器移植、先天性CMV感染、その他）
・サイトメガロウイルス病治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・サイトメガロウイルス病治療の販売チャネル・代理店・貿易業者・ディーラー分析

【レポートの概要】

Cytomegalovirus disease (CMV) is a viral infection that can affect one part of the body, such as the eyes, or it can spread throughout the body.

Scope of the Report:
The global Cytomegalovirus Disease Treatments market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cytomegalovirus Disease Treatments.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Cytomegalovirus Disease Treatments market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cytomegalovirus Disease Treatments market by product type and applications/end industries.

Market Segment by Companies, this report covers
Merck
Chimerix
Abbott
Bio-Rad
Roche
Gilead Sciences

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Ganciclovir
Valganciclovir
Foscarnet
Cidofovir
Others

Market Segment by Applications, can be divided into
Stem Cell Transplantation
Organ Transplantation
Congenital CMV Infection
Others

【レポートの目次】

Table of Contents

1 Cytomegalovirus Disease Treatments Market Overview
1.1 Product Overview and Scope of Cytomegalovirus Disease Treatments
1.2 Classification of Cytomegalovirus Disease Treatments by Types
1.2.1 Global Cytomegalovirus Disease Treatments Revenue Comparison by Types (2019-2024)
1.2.2 Global Cytomegalovirus Disease Treatments Revenue Market Share by Types in 2018
1.2.3 Ganciclovir
1.2.4 Valganciclovir
1.2.5 Foscarnet
1.2.6 Cidofovir
1.2.7 Others
1.3 Global Cytomegalovirus Disease Treatments Market by Application
1.3.1 Global Cytomegalovirus Disease Treatments Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Stem Cell Transplantation
1.3.3 Organ Transplantation
1.3.4 Congenital CMV Infection
1.3.5 Others
1.4 Global Cytomegalovirus Disease Treatments Market by Regions
1.4.1 Global Cytomegalovirus Disease Treatments Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Cytomegalovirus Disease Treatments Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cytomegalovirus Disease Treatments Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cytomegalovirus Disease Treatments Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Cytomegalovirus Disease Treatments Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cytomegalovirus Disease Treatments Status and Prospect (2014-2024)
1.5 Global Market Size of Cytomegalovirus Disease Treatments (2014-2024)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Business Overview
2.1.2 Cytomegalovirus Disease Treatments Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck Cytomegalovirus Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
2.2 Chimerix
2.2.1 Business Overview
2.2.2 Cytomegalovirus Disease Treatments Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Chimerix Cytomegalovirus Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
2.3 Abbott
2.3.1 Business Overview
2.3.2 Cytomegalovirus Disease Treatments Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Abbott Cytomegalovirus Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
2.4 Bio-Rad
2.4.1 Business Overview
2.4.2 Cytomegalovirus Disease Treatments Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bio-Rad Cytomegalovirus Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
2.5 Roche
2.5.1 Business Overview
2.5.2 Cytomegalovirus Disease Treatments Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Roche Cytomegalovirus Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
2.6 Gilead Sciences
2.6.1 Business Overview
2.6.2 Cytomegalovirus Disease Treatments Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Gilead Sciences Cytomegalovirus Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
3 Global Cytomegalovirus Disease Treatments Market Competition, by Players
3.1 Global Cytomegalovirus Disease Treatments Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Cytomegalovirus Disease Treatments Players Market Share
3.2.2 Top 10 Cytomegalovirus Disease Treatments Players Market Share
3.3 Market Competition Trend
4 Global Cytomegalovirus Disease Treatments Market Size by Regions
4.1 Global Cytomegalovirus Disease Treatments Revenue and Market Share by Regions
4.2 North America Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
4.3 Europe Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
4.5 South America Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
5 North America Cytomegalovirus Disease Treatments Revenue by Countries
5.1 North America Cytomegalovirus Disease Treatments Revenue by Countries (2014-2019)
5.2 USA Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
5.3 Canada Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
5.4 Mexico Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
6 Europe Cytomegalovirus Disease Treatments Revenue by Countries
6.1 Europe Cytomegalovirus Disease Treatments Revenue by Countries (2014-2019)
6.2 Germany Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
6.3 UK Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
6.4 France Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
6.5 Russia Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
6.6 Italy Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Cytomegalovirus Disease Treatments Revenue by Countries
7.1 Asia-Pacific Cytomegalovirus Disease Treatments Revenue by Countries (2014-2019)
7.2 China Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
7.3 Japan Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
7.4 Korea Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
7.5 India Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
8 South America Cytomegalovirus Disease Treatments Revenue by Countries
8.1 South America Cytomegalovirus Disease Treatments Revenue by Countries (2014-2019)
8.2 Brazil Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
8.3 Argentina Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
8.4 Colombia Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Cytomegalovirus Disease Treatments by Countries
9.1 Middle East and Africa Cytomegalovirus Disease Treatments Revenue by Countries (2014-2019)
9.2 Saudi Arabia Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
9.3 UAE Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
9.4 Egypt Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
9.5 Nigeria Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
9.6 South Africa Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
10 Global Cytomegalovirus Disease Treatments Market Segment by Type
10.1 Global Cytomegalovirus Disease Treatments Revenue and Market Share by Type (2014-2019)
10.2 Global Cytomegalovirus Disease Treatments Market Forecast by Type (2019-2024)
10.3 Ganciclovir Revenue Growth Rate (2014-2024)
10.4 Valganciclovir Revenue Growth Rate (2014-2024)
10.5 Foscarnet Revenue Growth Rate (2014-2024)
10.6 Cidofovir Revenue Growth Rate (2014-2024)
10.7 Others Revenue Growth Rate (2014-2024)
11 Global Cytomegalovirus Disease Treatments Market Segment by Application
11.1 Global Cytomegalovirus Disease Treatments Revenue Market Share by Application (2014-2019)
11.2 Cytomegalovirus Disease Treatments Market Forecast by Application (2019-2024)
11.3 Stem Cell Transplantation Revenue Growth (2014-2019)
11.4 Organ Transplantation Revenue Growth (2014-2019)
11.5 Congenital CMV Infection Revenue Growth (2014-2019)
11.6 Others Revenue Growth (2014-2019)
12 Global Cytomegalovirus Disease Treatments Market Size Forecast (2019-2024)
12.1 Global Cytomegalovirus Disease Treatments Market Size Forecast (2019-2024)
12.2 Global Cytomegalovirus Disease Treatments Market Forecast by Regions (2019-2024)
12.3 North America Cytomegalovirus Disease Treatments Revenue Market Forecast (2019-2024)
12.4 Europe Cytomegalovirus Disease Treatments Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Cytomegalovirus Disease Treatments Revenue Market Forecast (2019-2024)
12.6 South America Cytomegalovirus Disease Treatments Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Cytomegalovirus Disease Treatments Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Cytomegalovirus Disease Treatments Picture
Table Product Specifications of Cytomegalovirus Disease Treatments
Table Global Cytomegalovirus Disease Treatments and Revenue (Million USD) Market Split by Product Type
Figure Global Cytomegalovirus Disease Treatments Revenue Market Share by Types in 2018
Figure Ganciclovir Picture
Figure Valganciclovir Picture
Figure Foscarnet Picture
Figure Cidofovir Picture
Figure Others Picture
Table Global Cytomegalovirus Disease Treatments Revenue (Million USD) by Application (2014-2024)
Figure Cytomegalovirus Disease Treatments Revenue Market Share by Applications in 2018
Figure Stem Cell Transplantation Picture
Figure Organ Transplantation Picture
Figure Congenital CMV Infection Picture
Figure Others Picture
Table Global Market Cytomegalovirus Disease Treatments Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Cytomegalovirus Disease Treatments Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Cytomegalovirus Disease Treatments Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Cytomegalovirus Disease Treatments Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Cytomegalovirus Disease Treatments Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Cytomegalovirus Disease Treatments Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Cytomegalovirus Disease Treatments Revenue (Million USD) and Growth Rate (2014-2024)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Cytomegalovirus Disease Treatments Type and Applications
Table Merck Cytomegalovirus Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
Table Chimerix Basic Information, Manufacturing Base and Competitors
Table Chimerix Cytomegalovirus Disease Treatments Type and Applications
Table Chimerix Cytomegalovirus Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Cytomegalovirus Disease Treatments Type and Applications
Table Abbott Cytomegalovirus Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
Table Bio-Rad Basic Information, Manufacturing Base and Competitors
Table Bio-Rad Cytomegalovirus Disease Treatments Type and Applications
Table Bio-Rad Cytomegalovirus Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Cytomegalovirus Disease Treatments Type and Applications
Table Roche Cytomegalovirus Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
Table Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Cytomegalovirus Disease Treatments Type and Applications
Table Gilead Sciences Cytomegalovirus Disease Treatments Revenue, Gross Margin and Market Share (2017-2018)
Table Global Cytomegalovirus Disease Treatments Revenue (Million USD) by Players (2014-2019)
Table Global Cytomegalovirus Disease Treatments Revenue Share by Players (2014-2019)
Figure Global Cytomegalovirus Disease Treatments Revenue Share by Players in 2017
Figure Global Cytomegalovirus Disease Treatments Revenue Share by Players in 2018
Figure Global Top 5 Players Cytomegalovirus Disease Treatments Revenue Market Share in 2018
Figure Global Top 10 Players Cytomegalovirus Disease Treatments Revenue Market Share in 2018
Figure Global Cytomegalovirus Disease Treatments Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Cytomegalovirus Disease Treatments Revenue (Million USD) by Regions (2014-2019)
Table Global Cytomegalovirus Disease Treatments Revenue Market Share by Regions (2014-2019)
Figure Global Cytomegalovirus Disease Treatments Revenue Market Share by Regions (2014-2019)
Figure Global Cytomegalovirus Disease Treatments Revenue Market Share by Regions in 2018
Figure North America Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
Figure Europe Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
Figure South America Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
Table North America Cytomegalovirus Disease Treatments Revenue by Countries (2014-2019)
Table North America Cytomegalovirus Disease Treatments Revenue Market Share by Countries (2014-2019)
Figure North America Cytomegalovirus Disease Treatments Revenue Market Share by Countries (2014-2019)
Figure North America Cytomegalovirus Disease Treatments Revenue Market Share by Countries in 2018
Figure USA Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
Figure Canada Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
Figure Mexico Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
Table Europe Cytomegalovirus Disease Treatments Revenue (Million USD) by Countries (2014-2019)
Figure Europe Cytomegalovirus Disease Treatments Revenue Market Share by Countries (2014-2019)
Figure Europe Cytomegalovirus Disease Treatments Revenue Market Share by Countries in 2018
Figure Germany Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
Figure UK Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
Figure France Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
Figure Russia Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
Figure Italy Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Cytomegalovirus Disease Treatments Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Cytomegalovirus Disease Treatments Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Cytomegalovirus Disease Treatments Revenue Market Share by Countries in 2018
Figure China Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
Figure Japan Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
Figure Korea Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
Figure India Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
Table South America Cytomegalovirus Disease Treatments Revenue by Countries (2014-2019)
Table South America Cytomegalovirus Disease Treatments Revenue Market Share by Countries (2014-2019)
Figure South America Cytomegalovirus Disease Treatments Revenue Market Share by Countries (2014-2019)
Figure South America Cytomegalovirus Disease Treatments Revenue Market Share by Countries in 2018
Figure Brazil Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
Figure Argentina Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
Figure Colombia Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Cytomegalovirus Disease Treatments Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Cytomegalovirus Disease Treatments Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Cytomegalovirus Disease Treatments Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Cytomegalovirus Disease Treatments Revenue Market Share by Countries in 2018
Figure Saudi Arabia Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
Figure UAE Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
Figure Egypt Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
Figure Nigeria Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
Figure South Africa Cytomegalovirus Disease Treatments Revenue and Growth Rate (2014-2019)
Table Global Cytomegalovirus Disease Treatments Revenue (Million USD) by Type (2014-2019)
Table Global Cytomegalovirus Disease Treatments Revenue Share by Type (2014-2019)
Figure Global Cytomegalovirus Disease Treatments Revenue Share by Type (2014-2019)
Figure Global Cytomegalovirus Disease Treatments Revenue Share by Type in 2019
Table Global Cytomegalovirus Disease Treatments Revenue Forecast by Type (2019-2024)
Figure Global Cytomegalovirus Disease Treatments Market Share Forecast by Type (2019-2024)
Figure Global Ganciclovir Revenue Growth Rate (2014-2019)
Figure Global Valganciclovir Revenue Growth Rate (2014-2019)
Figure Global Foscarnet Revenue Growth Rate (2014-2019)
Figure Global Cidofovir Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Cytomegalovirus Disease Treatments Revenue by Application (2014-2019)
Table Global Cytomegalovirus Disease Treatments Revenue Share by Application (2014-2019)
Figure Global Cytomegalovirus Disease Treatments Revenue Share by Application (2014-2019)
Figure Global Cytomegalovirus Disease Treatments Revenue Share by Application in 2019
Table Global Cytomegalovirus Disease Treatments Revenue Forecast by Application (2019-2024)
Figure Global Cytomegalovirus Disease Treatments Market Share Forecast by Application (2019-2024)
Figure Global Stem Cell Transplantation Revenue Growth Rate (2014-2019)
Figure Global Organ Transplantation Revenue Growth Rate (2014-2019)
Figure Global Congenital CMV Infection Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Cytomegalovirus Disease Treatments Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Cytomegalovirus Disease Treatments Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Cytomegalovirus Disease Treatments Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Cytomegalovirus Disease Treatments Revenue Market Forecast (2019-2024)
Figure Europe Cytomegalovirus Disease Treatments Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Cytomegalovirus Disease Treatments Revenue Market Forecast (2019-2024)
Figure South America Cytomegalovirus Disease Treatments Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Cytomegalovirus Disease Treatments Revenue Market Forecast (2019-2024)

【掲載企業】

Merck、Chimerix、Abbott、Bio-Rad、Roche、Gilead Sciences、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ サイトメガロウイルス病治療の世界市場2019(Global Cytomegalovirus Disease Treatments Market 2019 by Company, Regions, Type and Application, Forecast to 2024)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp